Related Experiment Video

Updated: Jun 15, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Up-regulated expression of stathmin may be associated with hepatocarcinogenesis

Lin Gan1, Kun Guo, Yan Li

  • 1Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, PR China.

Oncology Reports
|March 6, 2010
PubMed

Insights

Silencing stathmin, a protein overexpressed in liver cancer, reduced tumor cell growth, increased cell death, and inhibited metastasis. Stathmin is a potential therapeutic target for hepatocellular carcinoma (HCC).

Area of Science:

  • Oncology
  • Molecular Biology
  • Hepatology

Background:

  • Stathmin is a microtubule-destabilizing protein.
  • It is overexpressed in various human cancers, including hepatocellular carcinoma (HCC).
  • Stathmin overexpression correlates with malignancy and poor therapeutic outcomes.

Purpose of the Study:

  • To investigate the effects of stathmin expression silencing on HCC cell behavior.
  • To determine the significance of stathmin in hepatocarcinogenesis and tumor progression.
  • To evaluate stathmin as a potential therapeutic target for HCC.

Main Methods:

  • Immunohistochemistry (IHC) to detect stathmin expression in liver tissues.
  • Small interfering RNAs (siRNAs) to inhibit stathmin in HCCLM3 cells.
  • Cell proliferation assays (CCK-8), apoptosis analysis (FACS), cell adhesion, migration, and invasion assays.

Main Results:

  • Stathmin expression was significantly upregulated in HCC tissues, particularly in metastatic cases.
  • siRNA-mediated stathmin silencing effectively reduced HCCLM3 cell proliferation.
  • Stathmin inhibition induced significant apoptosis, decreased cell adhesion, and suppressed migration and invasion.

Conclusions:

  • Stathmin expression is correlated with hepatocarcinogenesis and tumor progression.
  • Stathmin silencing demonstrates anti-cancer effects in HCC cells.
  • Stathmin represents a promising therapeutic target for hepatocellular carcinoma treatment.

Related Concept Videos

Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...